Our weekly summary of COVID-19 related trends, including key publications, ratings changes, asset class trends, financing conditions, and debt issuance. This week: – BioNTech/Pfizer’s announcement of 90% efficacy in phase 3 trials of its new vaccine offered hope that an end might be in sight to the COVID-19 crisis.